Originally published January 26, 2007 at 12:00 AM | Page modified January 26, 2007 at 4:13 PM
Investors swiftly approve Icos' sale to Eli Lilly
After an acrimonious three-month takeover battle, it took barely 12 minutes Thursday to bring the curtain down on Bothell-based Icos. Investors holding about two-thirds...
Seattle Times business reporter
After an acrimonious three-month takeover battle, it took barely 12 minutes Thursday to bring the curtain down on Bothell-based Icos.
Investors holding about two-thirds of Icos' stock voted to sell the 16-year-old company to Eli Lilly for $34 a share, or $2.28 billion, despite complaints that the developer of the popular impotence drug Cialis was being sold off too cheaply.
Icos will become a subsidiary of Indianapolis-based Lilly, its joint-venture partner in marketing Cialis. Most of Icos' 700 or so workers — including about 500 locally — will lose their jobs in the coming weeks and months.
The prospect of so many lost jobs was just one aspect of the deal that rankled many of the 150 or so shareholders and employees who filled the meeting space at Icos' leased headquarters building in Bothell.
Dissenters pointed to Cialis' success — its $971 million in 2006 sales beat the company's own forecast and delivered its first annual profit — and to the prospect of three more drugs soon entering clinical trials.
The general mood, though, seemed to be one of resigned dismay.
As Chairman and Chief Executive Paul Clark read out the vote totals that sealed Icos' fate, former employee Dan Schwenk leaned over to his neighbor and murmured, "Let the pillage begin."
The deal is expected to formally close after the end of stock market trading Monday.
Clark, who has led Icos since 1999, defended the sale much as he has since Lilly's first offer, $32 a share, was made public in October. After the meeting, Clark called $34 "a compelling share price for our investors."
But when asked if Icos still could have been successful as a stand-alone company, Clark responded, "Sure," and went on to praise the "extraordinarily talented people" who work there.
Indeed, Icos' own projections supporting the buyout show the Lilly-Icos joint venture, which marketed the drug and divided the profits, becoming increasingly profitable over the next decade. Icos itself projected net profits of $63 million for the current year, compared with an estimated $24 million for 2006.
However, the joint-venture deal gave Lilly an effective veto over any potential deal between Icos and a third party, meaning Icos had little negotiating room and Lilly had little reason to top its own bid.
![]()
In the end, 43.1 million of the nearly 66 million Icos shares were voted in favor of the Lilly deal, while 12.7 million were voted against it. (The rest either abstained or weren't voted.)
"To me, I feel this is somewhat of a sellout," said Richard Prince, of Kenmore, one of the shareholders who voted against the deal. "For whose benefit, I don't know."
Prince said he felt especially bad for Icos workers, most of whom will be losing their jobs.
Around 125 workers at Icos' contract-manufacturing plant will keep their positions, at least for the time being. Clark told The Seattle Times last month that Lilly intended to sell that operation to someone who would retain the work force.
Another 160 or so Icos employees will be part of a "transition team" to smooth Lilly's takeover, spokeswoman Lacy Fitzpatrick said. Those people will lose their jobs in anywhere from a month to several months, she said.
The remaining 400 or so workers, including around 215 locally, will lose their jobs within two weeks, Fitzpatrick said. They'll receive unspecified severance pay and outplacement services, Clark said. In certain "hardship" cases, where recently hired people relocated to be near Icos, the company will pay to move them back home if they so desire.
There will be little hardship in Icos' senior ranks, however. Ten top executives stand to collect $75.5 million in payments for severance, cashed-out stock options, restricted stock awards and various bonuses.
Drew DeSilver: 206-464-3145 or ddesilver@seattletimes.com
UPDATE - 09:46 AM
Exxon Mobil wins ruling in Alaska oil spill case
UPDATE - 09:32 AM
Bank stocks push indexes higher; oil prices dip
UPDATE - 08:04 AM
Ford CEO Mulally gets $56.5M in stock award
UPDATE - 07:54 AM
Underwater mortgages rise as home prices fall
NEW - 09:43 AM
Warner Bros. to offer movie rentals on Facebook

Entertainment | Top Video | World | Offbeat Video | Sci-Tech
general classifieds
Garage & estate salesFurniture & home furnishings
Electronics
just listed
American Bulldog pups NKC
Solar Panel Super Sale
***Stunning Akc POMERANIAN baby girl W/ FUL...
More listings
POST A FREE LISTING
- Lakewood cop accused of embezzling $150K meant for slain officers' families
- 3 big health insurers stockpile $2.4 billion as rates keep rising
- Agency set to investigate handling of 911 call about Josh Powell
- Quick decisions: How Washington hired its new football staff
- Historic day for gay marriage as another fight looms
- Justin Wilcox's versatile defensive style is the right fit for Huskies | Jerry Brewer
- It's Terrence Time: Enigmatic Ross leads Huskies
- Social worker recounts minutes before Powell fire
- $25B settlement reached over foreclosure abuses
- Club promoter convicted in brutal 2010 murder of Des Moines prostitute
- Gay-marriage bill passes House, awaits Gregoire's signature
444 - Historic day for gay marriage as another fight looming
350 - Sheriff's office unhappy with 911 dispatcher in caseworker's call
283 - 3 big health insurers stockpile $2.4 billion as rates keep rising
238 - Source: NY, California to sign mortgage settlement
225 - Wanted in Seattle classrooms: more teachers of color
188 - Oregon live game thread
155 - Pac-12 picks ... including the UW game
140 - Worker: Josh Powell told son he had 'surprise'
86 - Council members get briefing on arena proposal, minus details
85
- State Medicaid program to stop paying for unneeded ER visits
- 3 big health insurers stockpile $2.4 billion as rates keep rising
- Wanted in Seattle classrooms: more teachers of color
- One man's audacious pursuit of sailing history
- Darren Berg gets 18-year sentence for Ponzi scheme
- $25B settlement reached over foreclosure abuses
- 'Gauguin and Polynesia': dazzling mix-and-match | Art review
- A wandering gene's destructive path | Book review
- Economy, blogs give survivalists new reason to look to Northwest
- Navy fliers' love-hate relationship with water-crash survival class
